CyGenics Expands into Clinical Cell Therapy

Tuesday, 6 June 2006, 9:49 am | CyGenics

CyGenics Expands into Revenue Generating Clinical Cell Therapy Key Points: • Takes 20% stake in Pharmacell, with option to purchase 100% • Establishes European presence and develops into integrated global cell therapy company • Revenue expansion and ... More >>